40 results on '"Sandres-Sauné, Karine"'
Search Results
2. Genetic Heterogeneity of the NS5A Gene of Hepatitis C Virus and Early Response to Interferon-α
3. Evolution of Human Immunodeficiency Virus Type 1 Populations after Resumption of Therapy following Treatment Interruption and Shift in Resistance Genotype
4. Frequency of CXCR4-using viruses in primary HIV-1 infections using ultra-deep pyrosequencing
5. CXCR4-using viruses in plasma and peripheral blood mononuclear cells during primary HIV-1 infection and impact on disease progression
6. La diversification de la région hypervariable-1 du virus de l'hépatite C pourrait prédire l'évolution de la fibrose hépatique après transplantation rénale
7. Follow-up of 28 HCMV seropositive renal-transplant recipients: comparison of clinical, biological and virological parameters in the groups of treated versus untreated infected patients
8. Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism
9. Genetic Diversity of HCV Genotype 2 Strains in South Western France
10. Twenty-Four Hour Kinetics of Hepatitis C Virus and Antiviral Effect of Alpha-Interferon
11. Persistence of distinct HIV-1 populations in blood monocytes and naive and memory CD4 T cells during prolonged suppressive HAART
12. Incidence of HCV Infection in French Hemodialysis Units: A Prospective Study
13. Effects of long-term lamivudine therapy in renal-transplant patients
14. Amantadine therapy in renal transplant patients with hepatitis C virus infection
15. Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology
16. Genotypic prediction of HIV-1 subtype D tropism
17. Evolution of Total and Integrated HIV-1 DNA and Change in DNA Sequences in Patients with Sustained Plasma Virus Suppression
18. JC VIRUS DNA IN THE PERIPHERAL BLOOD OF RENAL TRANSPLANT PATIENTS: A ONE-YEAR PROSPECTIVE FOLLOW-UP IN FRANCE
19. Hepatitis C virus infection among pregnant women in Yaounde, Cameroon: prevalence, viremia, and genotypes
20. Genotypic Prediction of HIV-1 CRF01-AE Tropism
21. Genotypic prediction of HIV-1 subtype D tropism
22. Prediction of HIV Type 1 Subtype C Tropism by Genotypic Algorithms Built From Subtype B Viruses
23. Development and performance of a new recombinant virus phenotypic entry assay to determine HIV-1 coreceptor usage
24. Genotypic Prediction of Human Immunodeficiency Virus Type 1 CRF02-AG Tropism
25. Pegylation of IFN-α and Antiviral Activity
26. Genetic diversity of HCV genotype 2 strains in South Western France
27. Naïve T-Cell Depletion Related to Infection by X4 Human Immunodeficiency Virus Type 1 in Poor Immunological Responders to Highly Active Antiretroviral Therapy
28. R5 to X4 Switch of the Predominant HIV-1 Population in Cellular Reservoirs During Effective Highly Active Antiretroviral Therapy
29. HIV therapy after treatment interruption in patients with multiple failure and more than 200 CD4+T lymphocyte count
30. High rate of hepatitis C virus infection and predominance of genotype 4 among elderly inhabitants of a remote village of the rain forest of South Cameroon
31. Assessment of HIV-1 subtyping for Cameroon strains using phylogenetic analysis of pol gene sequences
32. Quantitation of human cytomegalovirus in recipients of solid organ transplants by real‐time quantitative PCR and pp65 antigenemia
33. Virological and immunological effects of salvage therapy following treatment interruption and a shift in HIV‐1 resistance genotype
34. Genetic heterogeneity of the envelope 2 gene and eradication of hepatitis C virus after a second course of interferon‐α
35. Screening of blood from potential organ and cornea donors for viruses
36. Quantitation of human cytomegalovirus in recipients of solid organ transplants by real-time quantitative PCR and pp65 antigenemia.
37. Prediction of HIV type 1 subtype C tropism by genotypic algorithms built from subtype B viruses.
38. Pegylation of IFN-alpha and antiviral activity.
39. HIV therapy after treatment interruption in patients with multiple failure and more than 200 CD4+ T lymphocyte count.
40. Genetic heterogeneity of the envelope 2 gene and eradication of hepatitis C virus after a second course of interferon-alpha.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.